Kyle Guse - Aug 13, 2025 Form 4 Insider Report for PLUS THERAPEUTICS, INC. (PSTV)

Role
Director
Signature
/s/ Andrew Sims, attorney-in-fact
Stock symbol
PSTV
Transactions as of
Aug 13, 2025
Transactions value $
$0
Form type
4
Date filed
8/15/2025, 04:29 PM
Previous filing
Aug 15, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Guse Kyle Director C/O PLUS THERAPEUTICS INC., 4200 MARATHON BOULEVARD, SUITE 200, AUSTIN /s/ Andrew Sims, attorney-in-fact 2025-08-15 0001566618

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PSTV Stock Option (Right to Buy) Award $0 +298K $0.00 298K Aug 13, 2025 Common Stock 298K $0.57 Direct F1
transaction PSTV Stock Option (Right to Buy) Award $0 +40K $0.00 40K Aug 13, 2025 Common Stock 40K $0.57 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's 2026 Annual Stockholder Meeting, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.
F2 The options vest monthly over 24 months from the Grant Date in substantially equal monthly installments.